# Rigel Pharmaceuticals Inc: Form 8-K, filed Nov 30, 2023

- Company: [Rigel Pharmaceuticals Inc](/companies/rigl.md) (CIK 1034842)
- Form: 8-K
- Filed: 2023-11-30
- Accepted by EDGAR: Nov 30, 2023, 06:04 ET
- Period: 2023-11-27
- Accession: 0001104659-23-122171
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1034842/000110465923122171/tm2331763d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1034842/000110465923122171/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1034842/000110465923122171/tm2331763d1_8k.htm

Filed Nov 30, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-122171. Last ingested by Listed: Nov 14, 2026, 23:09 ET. No prices; not investment advice.
